Mandatory information
Bromelain tablets hysan®
Bromelaintabletten hysan® (bromelain tablets hysan®)
Active ingredient: Bromelain. Therapeutic indications: for supportive treatment in acute post-operative and post-traumatic swelling, particularly of nose and paranasal sinuses. For information on risks and side effects read the package leaflet and ask your doctor or pharmacist. October 2019
URSAPHARM Arzneimittel GmbH, Industriestraße 35, 66129 Saarbrücken, Germany
BilanCyn®
BilanCyn® Hard capsules 400 mg.
Active substance: Artichoke leaf dry extract. Therapeutic indications: A traditional herbal medicine for the symptomatic relief of digestive disorders with bloating or flatulence. To find out about risks and side effects, read the package leaflet and ask your doctor or pharmacist.
URSAPHARM Arzneimittel GmbH, Industriestraße 35, 66129 Saarbrücken, www.ursapharm.de
Last revised: December 2018
Bromelain-POS®
Bromelain-POS®
500 FIP units, gastro-resistant tablets.
Active ingredient: bromelain.
Therapeutic indications: supportive treatment of post-operative and post-traumatic swelling, particularly that of the nose and sinuses. For information on risks and side effects read the package leaflet and ask your doctor or pharmacist. October 2019
URSAPHARM Arzneimittel GmbH, Industriestraße 35, 66129 Saarbrücken, Germany.
hysan® rhinitis spray
hysan® Schnupfenspray (hysan® rhinitis spray).
1 mg/ml nasal spray, solution. Active ingredient: Xylometazolin hydrochlorid. Therapeutic indications: short term treatment to reduce the swelling (congestion) of the nasal mucosa.
For risks and side effects please read the package insert or ask your doctor or pharmacist. October 2019
URSAPHARM Arzneimittel GmbH, Industriestraße 35, 66129 Saarbrücken, Germany.
hysan® rhinitis spray children
hysan® Schnupfenspray Kinder (hysan® rhinitis spray children).
0,5 mg/ml nasal spray, solution. Active ingredient: Xylometazolin hydrochlorid. Therapeutic indications: Reduces the swelling of the nasal mucosa caused by rhinitis, a runny nose (rhinitis vasomotorica) or an allergic rhinitis. Facilitates the clearing of secretion during a sinus infection or a rhinitis induced catarrh of the middle ear. For risks and side effects please read the package insert or ask your doctor or pharmacist. October 2019
URSAPHARM Arzneimittel GmbH, Industriestraße 35, 66129 Saarbrücken, Germany.
Pollicrom® nasal spray
Pollicrom® 20 mg/ml nasal spray, solution. Active ingredient: Sodium cromoglicate (Ph. Eur.) 20 mg/ml.
Areas of application: Year round allergic rhinitis and hay fever (seasonal allergic rhinitis). For risks and side effects, please read the package insert and consult your doctor or pharmacist.
URSAPHARM Arzneimittel GmbH, Industriestraße 35, 66129 Saarbrücken, www.ursapharm.de
Version: August 2017
Posiformin® 2%, eye ointment
Posiformin® 2%, eye ointment. Active ingredient: Bibrocathol. Therapeutic indications: Irritiation of the outer eye that are not caused by bacteria, chronic (long lasting) inflammation of the eye lid margin that are not caused by bacteria and non-infectious fresh wounds of the cornea. For risks and side effects read the package leaflet and ask your doctor or pharmacist.
URSAPHARM Arzneimittel GmbH, Industriestraße 35, 66129 Saarbrücken, www.ursapharm.de October 2019
POSIFORLID COMOD®
POSIFORLID COMOD® eye drops
Active ingredient: Salicylic acid (Ph. Eur.) Therapeutic indications: For symptomatic therapy of blepharitis, unspecific conjunctivitis, irritations caused by dust, smoke, sun. During infectious diseases this product should not be applied without adequate anti-infectious adjunctive therapy. For information on risks and side effects read the package leaflet and ask your doctor or pharmacist. October 2019
URSAPHARM Arzneimittel GmbH, Industriestraße 35, 66129 Saarbrücken, Germany.
Pollicrom® eye drops
Pollicrom® 20 mg/ml eye drops. Active ingredient: Sodium cromoglicate (Ph. Eur.) 20 mg/ml.
Areas of application: For usage with allergy-related acute and chronic conjunctivitis, for example hay fever conjunctivitis, vernal catarrh ((keratoconjunctivitis) vernal conjunctivitis). For risks and side effects, please read the package insert and consult your doctor or pharmacist.
URSAPHARM Arzneimittel GmbH, Industriestraße 35, 66129 Saarbrücken, www.ursapharm.de
Version: August 2017
Pollival® nasal spray
Pollival® 1 mg/ml nasal spray, solution. Active ingredient: Azelastine hydrochloride 1 mg/ml.
Areas of application: Symptomatic treatment of hay fever (seasonal allergic rhinitis). Pollival 1 mg/ml nasal spray is suitable for adults and children from 6 years of age. For risks and side effects, please read the package insert and consult your doctor or pharmacist.
URSAPHARM Arzneimittel GmbH, Industriestraße 35, 66129 Saarbrücken, www.ursapharm.de
Version: August 2017
Pollival® eye drops
Pollival® 0,5 mg/ml eye drops, solution. Active ingredient: Azelastine hydrochloride.
Areas of application: Treatment and prevention of eye disorders related to hay fever (seasonal allergic conjunctivitis) occurring in adults and children over 4 years. Treatment of eye disorders related to dust mites or animal hair (non-seasonal year-round allergic conjunctivitis) occurring in adults and children over 12 years. For risks and side effects, please read the package insert and consult your doctor or pharmacist.
URSAPHARM Arzneimittel GmbH, Industriestraße 35, 66129 Saarbrücken, www.ursapharm.de
Version: September 2017
Siccapos® Gel
Siccapos® Gel.
Active ingredient: Polyacrylic acid (Carbomer 980). Therapeutic indications: Artificial tear solution during tear deficiency and dry eye. For information on risks and side effects read the package leaflet and ask your doctor or pharmacist. October 2019
URSAPHARM Arzneimittel GmbH, Industriestraße 35, 66129 Saarbrücken, Germany.
Siccaprotect®
Siccaprotect®
Active ingredient: Dexpanthenol and polyvinyl alcohol. Therapeutic indications: For symptomatic treatment of desiccation symptoms of the cornea and the conjunctiva due to tear secretion disorder caused by local or systemic (concerning the whole body) primary disease. Also applicable when having problems with closing the eyelids; and for additional wetting of hard contact lenses during the day. For information on risks and side effects read the package leaflet and ask your doctor or pharmacist. October 2019
URSAPHARM Arzneimittel GmbH, Industriestraße 35, 66129 Saarbrücken, Germany.
Veno SL® 300
Veno SL® 300.
Active substance: Troxerutin. Therapeutic indications: Counteracting the formation of oedemas (oedema-protective agent), improving blood flow, providing supportive treatment of the accumulation of fluid in the tissue (exudative processes) and stabilising blood vessels that have become fine and fragile (capillary fragility). For risks and side effects, read the package leaflet and ask your doctor or pharmacist.
URSAPHARM Arzneimittel GmbH, Industriestraße 35, 66129 Saarbrücken, www.ursapharm.de. Date of revision of the text: March 2019
Vasopos® N
Vasopos® N
Active ingredient: Tetryzoline hydrochloride. Therapeutic indications: For symptomatic therapy of conjunctivitis which is not caused by pathogens. For information on risks and side effects read the package leaflet and ask your doctor or pharmacist. October 2019
URSAPHARM Arzneimittel GmbH, Industriestraße 35, 66129 Saarbrücken, Germany.
Zinkorotat-POS®
Zinkorotat-POS® 40 mg, gastro-resistant tablets.
Active ingredient: Zinc orotate x 2 H2O. Therapeutic indications: Zinc deficiency that cannot be corrected by dietary means.
For information on risks and side effects read the package leaflet and ask your doctor or pharmacist. October 2019
URSAPHARM Arzneimittel GmbH, Industriestraße 35, 66129 Saarbrücken, Germany.
Zink-POS® 3,2 mg
Zink-POS® 3,2 mg
Active ingredient: Zinc orotate x 2 H2O. Therapeutic indications: For the treatment of zinc deficiencies which cannot be remedied by diet. For information on risks and side effects read the package leaflet and ask your doctor or pharmacist. October 2019
URSAPHARM Arzneimittel GmbH, Industriestraße 35, 66129 Saarbrücken, Germany.